Medicare’s add-on payments aim to boost AI adoption in hospitals
Medicare is offering temporary extra payments for new AI-based medical devices, hoping the financial incentive will encourage hospitals to adopt the technology.
Artificial-intelligence solutions promise both clinical improvements and cost reductions for hospitals, yet convincing health systems of a solid return on investment remains challenging. Medicare has introduced a program that grants additional payments for qualifying AI-based medical devices for a limited period of two or three years after market entry. Funded by tax dollars, the add-on payments aim to lower the financial barrier for adopting expensive, cutting-edge technologies.
For AI startups, the temporary boost helps demonstrate value and persuade hospitals to integrate their products into standard practice. The policy reflects a broader strategy to accelerate the diffusion of advanced medical tools by tying reimbursement to innovation. If successful, the approach could reshape how hospitals evaluate and purchase AI-driven equipment.
Why it matters
Medicare’s incentives could speed up AI integration in care, affecting costs and patient outcomes nationwide.
In this story